Reed Smith advises Webster Equity Partners on sale of CenExel
1 Articles
1 Articles
Reed Smith advises Webster Equity Partners on sale of CenExel
Global law firm Reed Smith today announced that it provided regulatory counsel to Webster Equity Partners and its portfolio company, CenExel Clinical Research, on a definitive agreement to sell CenExel to investment firm BayPine. The terms of the transaction are not disclosed, and it is subject to customary closing conditions and regulatory approvals.CenExel is a leading clinical trial site network focused on complex therapeutic areas. The trans…
Coverage Details
Bias Distribution
- 100% of the sources lean Right
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage